Modulation of Tumor Necrosis Factor by Microbial Pathogens

por Rahman, Masmudur M, McFadden, Grant
Publicado 2006

Modulation of NF-κB signalling by microbial pathogens

por Rahman, Masmudur M., McFadden, Grant
Publicado 2011

Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion

por Rahman, Masmudur M., McFadden, Grant
Publicado 2017

Oncolytic Virotherapy with Myxoma Virus

por Rahman, Masmudur M., McFadden, Grant
Publicado 2020

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways

por Rahman, Masmudur M., McFadden, Grant
Publicado 2020

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy

por Rahman, Masmudur M., McFadden, Grant
Publicado 2021

Role of cytokines in poxvirus host tropism and adaptation

por Rahman, Masmudur M, McFadden, Grant
Publicado 2022

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy

por Enow, Junior A., Sheikh, Hummad I., Rahman, Masmudur M.
Publicado 2023

Cytokine determinants of viral tropism

por McFadden, Grant, Mohamed, Mohamed R., Rahman, Masmudur M., Bartee, Eric
Publicado 2009

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

por Villa, Nancy Y., Rahman, Masmudur M., McFadden, Grant, Cogle, Christopher R.
Publicado 2016

Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells

por Rahman, Masmudur M., Bagdassarian, Eugenie, Ali, Mohamed A. M., McFadden, Grant
Publicado 2017

Co-Regulation of NF-κB and Inflammasome-Mediated Inflammatory Responses by Myxoma Virus Pyrin Domain-Containing Protein M013

por Rahman, Masmudur M., Mohamed, Mohamed R., Kim, Manbok, Smallwood, Sherin, McFadden, Grant
Publicado 2009

Oncolytic Virotherapy for Hematological Malignancies

por Bais, Swarna, Bartee, Eric, Rahman, Masmudur M., McFadden, Grant, Cogle, Christopher R.
Publicado 2012

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication

por Rahman, Masmudur M., Liu, Jia, Chan, Winnie M., Rothenburg, Stefan, McFadden, Grant
Publicado 2013

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma

por Phelps, Michael P., Yang, Heechang, Patel, Shivani, Rahman, Masmudur M., McFadden, Grant, Chen, Eleanor
Publicado 2018

RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells

por Rahman, Masmudur M., Gutierrez-Jensen, Ami D., Glenn, Honor L., Abrantes, Mario, Moussatche, Nissin, McFadden, Grant
Publicado 2021

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma

por Jazowiecka-Rakus, Joanna, Sochanik, Aleksander, Hadryś, Agata, Fidyk, Wojciech, Chmielik, Ewa, Rahman, Masmudur M., McFadden, Grant
Publicado 2022

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy

por Cornejo, Yvonne, Li, Min, Dellinger, Thanh H., Mooney, Rachael, Rahman, Masmudur M., McFadden, Grant, Aboody, Karen S., Hammad, Mohamed
Publicado 2020

Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo

por Ogbomo, Henry, Zemp, Franz J., Lun, Xueqing, Zhang, Jiqing, Stack, Danuta, Rahman, Masmudur M., Mcfadden, Grant, Mody, Christopher H., Forsyth, Peter A.
Publicado 2013

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase

por Woo, Yanghee, Warner, Susanne G, Geha, Rula, Stanford, Marianne M, Decarolis, Penelope, Rahman, Masmudur M, Singer, Samuel, McFadden, Grant, Fong, Yuman
Publicado 2021